Answers are grounded in this paper and cite their sources.
This research demonstrates a green process that improves yields of fluorobenzene derivatives, indicating a sustainable solution for chemical synthesis.
Despite the pivotal role of fluorine in modern drug discovery, conventional syntheses of fluorobenzene derivatives suffer from limitations such as harsh conditions, hazardous by-products, and poor functional group tolerance. To address these challenges, we report a robust, green, and scalable process starting from substituted diazonium tetrafluoroborates. Our method has higher security, operates in an anhydrous system to minimize corrosion, and enables the recovery and reuse of both HF and generated fluoroboric acid, while avoiding BF₃ formation. This practical protocol delivers superior yields for a broad range of fluorobenzene derivatives, offering an efficient and sustainable alternative for pharmaceutical and fine chemical synthesis.
No takes yet. Share an insight, caveat, or question.
zeng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: